CureSound specializes in noninvasive medical devices and is the developer of the BRH-A wound-healing series. The BRH-A2 is a noninvasive, FDA-cleared portable device designed to heal chronic ulcers, reduce the size of lesions, lessen wound pain, and accelerate tissue regrowth through a combination of therapeutic ultrasound and electrostimulation in modulating cycles of independent and joint activity. CureSound won the 8200 Israeli Startup Competition in June 2013.